Valuation Amarin Corporation plc

Stocks

Real-time Estimate Cboe BZX Other stock markets 23:05:48 15/07/2026 +04			5-day change	1st Jan Change
14.56 ^USD	+1.36%		-5.34%	+2.90%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
07-01	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	301.3	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	3.85%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	127.5	113.8	109.3
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-18.03%	-10.68%	-3.97%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-479x	-719x	-359x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	7.2x	21.6x	-4x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.69x	1.9x	2.15x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.72x	0.72x	0.78x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-4.98x	-5.52x	-3.88x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-4.98x	-5.52x	-3.88x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.03	-0.02	-0.04
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	177.8	158.8	140.2
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-12.75	-9.038	-16.28
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	14.37	14.37	14.37
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AMARIN CORPORATION PLC	-479x	0.72x	-4.98x	-	301M
ARGENX SE	32.61x	8.24x	25.58x	0.06%	54.49B
WUXI APPTEC CO., LTD.	21.19x	6.45x	14.07x	1.5%	55.93B
INSMED INCORPORATED	-42.46x	13.79x	-40.26x	-.--%	23.87B
BIONTECH SE	-17.97x	4.21x	-7.37x	-.--%	22.86B
WUXI BIOLOGICS (CAYMAN) INC.	25.03x	4.92x	12.99x	-.--%	20B
GENMAB A/S	24.3x	4.76x	15.52x	-.--%	17.48B
PHARMAESSENTIA CORPORATION	46.08x	18.68x	48.09x	0.08%	15.39B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-520.13x	36.57x	-4077.48x	-.--%	15.19B
EXELIXIS, INC.	17.52x	5.09x	11.85x	-.--%	14.02B
Average	-89.28x	10.34x	-400.20x	0.18%	23.95B
Weighted average by Cap.	-19.32x	9.73x	-248.24x	0.37%